Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: A randomized, controlled trial

World Journal of Gastroenterology

Volumn 12, Issue 11, 2006, Pages 1770-1773

  Ji, Feng ^a   Wang, Zi Wei ^a   Ning, Jian Wen ^a   Wang, Qun Yan ^a   Chen, Jian Yong ^b   Li, You Ming ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Hanghzou Red Cross Hospital   (China)

Author keywords

Helicobacter pylori; Hyperplastic gastric polyps; Therapy

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; LANSOPRAZOLE; OMEPRAZOLE; PROTECTIVE AGENT; PROTON PUMP INHIBITOR; TEPRENONE; TINIDAZOLE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ERADICATION THERAPY; FEMALE; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STOMACH POLYP; TREATMENT OUTCOME;

EID: 33645845719     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i11.1770     Document Type: Article

References (10)

1. Daibo M, Itabashi M, Hirota T. Malignant transformation of gastric hyperplastic polyps. Am J Gastroenterol 1987; 82: 1016-1025
2. Nishi Y, Isomoto H, Mukae H, Ishimoto H, Wen CY, Wada A, Ohnita K, Mizuta Y, Murata I, Hirayama T, Nakazato M, Kohno S. Concentrations of alpha- and beta-defensins in gastric juice of patients with various gastroduodenal diseases. World J Gastroenterol 2005; 11: 99-103
3. Veereman Wauters G, Ferrell L, Ostroff JW, Heyman MB. Hyperplastic gastric polyps associated with persistent Helicobacter pylori infection and active gastritis. Am J Gastroenterol 1990; 85: 1395-1397
4. Ljubicic N, Kujundzic M, Roic G, Banic M, Cupic H, Doko M, Zovak M. Benign epithelial gastric polyps - frequency, location, and age and sex distribution. Coll Antropol 2002; 26: 55-60
5. Ohkusa T, Takashimizu I, Fujiki K, Suzuki S, Shimoi K, Horiuchi T, Sakurazawa T, Ariake K, Ishii K, Kumagai J, Tanizawa T. Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial. Ann Intern Med 1998; 129: 712-715
6. Ljubicic N, Banic M, Kujundzic M, Antic Z, Vrkljan M, Kovacevic I, Hrabar D, Doko M, Zovak M, Mihatov S. The effect of eradicating Helicobacter pylori infection on the course of adenomatous and hyperplastic gastric polyps. Eur J Gastroenterol Hepatol 1999; 11:727-730
7. Laxen F, Sipponen P, Ihamaki T, Hakkiluoto A, Dortscheva Z. Gastric polyps; their morphological and endoscopical characteristics and relation to gastric carcinoma. CActa Pathol Microbiol Immunol Scand 1982; 90:221-228
8. Gencosmanoglu. R, Sen-Oran E, Kurtkaya-Yapicier O, Avsar E, Sav A, Tozun N. Gastric polypoid lesions: analysis of 150 endoscopic polypectomy specimens from 91 patients. World J Gastroenterol 2003; 9: 2236-2239
9. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Patho 1996; 20:1161-1181
10. Yasunaga Y, Shinomura Y, Kanayama S, Higashimoto Y, Yabu M, Miyazaki Y, Kondo S, Murayama Y, Nishibayashi H, Kitamura S, Matsuzawa Y. Increased production of interleukin 1 beta and hepatocyte growth factor may contribute to foveolar hyperplasia in enlarged fold gastritis. Gut 1996; 39: 787-794